NBGI Ventures logo

NBGI Ventures

Europe, England, United Kingdom, London

Description

NBGI Ventures is a venture capital fund focused on investing in medical technology companies.

Investor Profile

NBGI Ventures has made 19 investments, with 0 in the past 12 months and 16% as lead.

Stage Focus

  • Series Unknown (37%)
  • Series B (26%)
  • Series A (11%)
  • Series C (11%)
  • Private Equity (5%)
  • Series D (5%)
  • Post Ipo Equity (5%)

Country Focus

  • France (37%)
  • United States (26%)
  • United Kingdom (16%)
  • Sweden (5%)
  • Denmark (5%)
  • Switzerland (5%)
  • Germany (5%)

Industry Focus

  • Health Care
  • Medical Device
  • Manufacturing
  • Biotechnology
  • Medical
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Clinical Trials
  • Diabetes
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NBGI Ventures frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
Bioam Gestion
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Kuwait Life Sciences Company
Asia, Al Kuwayt, Kuwait, Safat
Co-Investments: 2
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Saints Capital
North America, California, United States, San Francisco
Co-Investments: 2
TH
North America, California, United States, San Francisco
Co-Investments: 2
IXO Private Equity
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2
Innovations Kapital
Europe, Vastra Gotaland, Sweden, Göteborg
Co-Investments: 2
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5

What are some of recent deals done by NBGI Ventures?

Quanta

Alcester, Warwickshire, United Kingdom

Quanta develops an advanced haemodialysis systems for use in the home and clinic.

Clinical TrialsHealth CareManufacturingMedicalMedical Device
Series BNov 3, 2014
Amount Raised: $43,131,059
EPIX Therapeutics

Laguna Beach, California, United States

EPIX Therapeutics develops and commercializes microwave radiometry-based products for electrophysiology tests.

BiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownApr 21, 2014
Amount Raised: $7,300,000
DYSIS Medical

Livingston, West Lothian, United Kingdom

DYSIS Medical is focused on developing imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

Health CareLife ScienceManufacturingMedicalMedical DevicePharmaceutical
Series UnknownApr 15, 2013
Amount Raised: $11,319,433
SuperSonic Imagine

Aix-en-provence, Provence-Alpes-Cote d'Azur, France

SuperSonic Imagine develops and manufactures ultrasound medical imaging systems for evaluating and visualizing tissue elasticity.

BiotechnologyHealth CareManufacturingMedical Device
Private EquityApr 2, 2013
Amount Raised: $35,900,704
CellNovo

Paris, Ile-de-France, France

CellNova is a medical technology company that specializes in diabetes.

BiotechnologyDiabetesHealth CareMedical Device
Series BFeb 4, 2011
Amount Raised: $48,280,879
Estech

San Ramon, California, United States

ESTECH is a medical device manufacturing and distribution company offering products for cardiac surgery.

Health CareManufacturingMedical Device
Series DDec 7, 2010
Amount Raised: $8,500,000
SuperSonic Imagine

Aix-en-provence, Provence-Alpes-Cote d'Azur, France

SuperSonic Imagine develops and manufactures ultrasound medical imaging systems for evaluating and visualizing tissue elasticity.

BiotechnologyHealth CareManufacturingMedical Device
Series CNov 29, 2010
Amount Raised: $45,250,352
Symetis

Ecublens, Vaud, Switzerland

Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.

BiotechnologyHealth CareMedical
Series COct 8, 2010
Amount Raised: $25,800,000
Reverse Medical

Irvine, California, United States

Reverse Medical is a commercial-stage medical device company focused on revascularizing patients who experience acute ischemic strokes.

BiotechnologyHealth DiagnosticsPharmaceutical
Series BApr 7, 2010
Amount Raised: $14,000,000
EPIX Therapeutics

Laguna Beach, California, United States

EPIX Therapeutics develops and commercializes microwave radiometry-based products for electrophysiology tests.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BJan 11, 2010
Amount Raised: $5,000,000